{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:37:52Z","timestamp":1792143472101,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.gendis.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:09:21Z","timestamp":1618963761000},"page":"80-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Zhoupeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-2288","authenticated-orcid":false,"given":"Yongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-1331","authenticated-orcid":false,"given":"Mingkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1348-0421.12669","article-title":"Cytosolic DNA-sensing immune response and viral infection","volume":"63","author":"Abe","year":"2019","journal-title":"Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.gendis.2021.03.007_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections-more than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biotechadv.2017.12.016","article-title":"In\u00a0vitro methods for testing antiviral drugs","volume":"36","author":"Rumlova","year":"2018","journal-title":"Biotechnol Adv"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1568026618666180221114515","article-title":"Bis-coumarin derivatives and their\u00a0biological activities","volume":"18","author":"Ren","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"14","key":"10.1016\/j.gendis.2021.03.007_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bmcl.2019.05.019","article-title":"Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus","volume":"29","author":"Hu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"10.1016\/j.gendis.2021.03.007_bib8","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.bmcl.2017.04.091","article-title":"Anti-influenza activity of monoterpene-containing substituted coumarins","volume":"27","author":"Khomenko","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"8\u20139","key":"10.1016\/j.gendis.2021.03.007_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/minf.201501034","article-title":"Rational design, synthesis and evaluation of coumarin derivatives as protein-protein interaction inhibitors","volume":"35","author":"De Luca","year":"2016","journal-title":"Mol Inform"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib10","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.bmc.2013.01.025","article-title":"Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors","volume":"21","author":"Olomola","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.semdp.2017.04.008","article-title":"Human immunodeficiency virus: diagnostic approach","volume":"34","author":"Guarner","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/COH.0000000000000344","article-title":"Future technologies for monitoring HIV drug resistance and cure","volume":"12","author":"Parikh","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.gendis.2021.03.007_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jviromet.2016.11.010","article-title":"HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing","volume":"243","author":"Chimukangara","year":"2017","journal-title":"J Virol Methods"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2174\/1568026616999151013124606","article-title":"Why do we need new drug classes for HIV treatment and prevention?","volume":"16","author":"Waheed","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/1440-1681.13151","article-title":"Role of medicinal plants in HIV\/AIDS therapy","volume":"46","author":"Laila","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.fitote.2011.06.006","article-title":"Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico","volume":"82","author":"Cesar","year":"2011","journal-title":"Fitoterapia"},{"issue":"6","key":"10.1016\/j.gendis.2021.03.007_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1310\/9GDE-F2R1-W2RL-E9FJ","article-title":"Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers","volume":"3","author":"Eiznhamer","year":"2002","journal-title":"HIV Clin Trials"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/b402985m","article-title":"Natural products to drugs: natural product derived compounds in clinical trials","volume":"22","author":"Butler","year":"2005","journal-title":"Nat Prod Rep"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/jm901653e","article-title":"Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile","volume":"53","author":"Xue","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.gendis.2021.03.007_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fphar.2017.00479","article-title":"Metabolism of F18, a derivative of calanolide A, in human liver microsomes and cytosol","volume":"8","author":"Wu","year":"2017","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.gendis.2021.03.007_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0968-0896(00)82054-4","article-title":"Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides","volume":"2","author":"Lee","year":"1994","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10.1016\/j.gendis.2021.03.007_bib22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0960-894X(03)00201-4","article-title":"Anti-HIV agents. Part 55: 3'R,4'R-Di-(O)-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP), a novel anti-HIV agent","volume":"13","author":"Yu","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0960-894X(98)00254-6","article-title":"Anti-AIDS agents. 31. Synthesis and anti-HIV activity of 4-substituted 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) thiolactone analogs","volume":"8","author":"Yang","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.gendis.2021.03.007_bib24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0960-894X(00)00126-8","article-title":"Anti-AIDS agents part 41: synthesis and anti-HIV activity of 3',4'-di-o-(-)-camphanoyl-(+)-cis-khellactone (DCK) lactam analogues","volume":"10","author":"Yang","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/jm000070g","article-title":"Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone analogues","volume":"44","author":"Xie","year":"2001","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.gendis.2021.03.007_bib26","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/jm9900624","article-title":"Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3'R,4'R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents","volume":"42","author":"Xie","year":"1999","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.gendis.2021.03.007_bib27","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0960-894X(98)00367-9","article-title":"Anti-AIDS agents. 33. Synthesis and anti-HIV activity of mono-methyl substituted\u00a03',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) analogues","volume":"8","author":"Xie","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"10.1016\/j.gendis.2021.03.007_bib28","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0960-894X(01)00437-1","article-title":"Anti-AIDS agents. Part 47: synthesis and anti-HIV activity of 3-substituted 3',4'-Di-O-(S)-camphanoyl-(3'R,4'R)-(+)-cis-khellactone derivatives","volume":"11","author":"Xie","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"issue":"23","key":"10.1016\/j.gendis.2021.03.007_bib29","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/jm00049a014","article-title":"Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs","volume":"37","author":"Huang","year":"1994","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.virol.2004.11.033","article-title":"Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives","volume":"332","author":"Huang","year":"2005","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib31","first-page":"3341","article-title":"Anti-AIDS agents. Part 58: synthesis and anti-HIV activity of 1-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (1-thia-DCK) analogues","volume":"14","author":"Xia","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"16","key":"10.1016\/j.gendis.2021.03.007_bib32","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1021\/jm0400505","article-title":"Anti-AIDS agents. 60. Substituted 3'R,4'R-di-O-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) analogues as potent anti-HIV agents","volume":"47","author":"Yu","year":"2004","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/jm030416y","article-title":"Anti-AIDS agents. 52. Synthesis and anti-HIV activity of hydroxymethyl (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone derivatives","volume":"47","author":"Xie","year":"2004","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.gendis.2021.03.007_bib34","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1124\/dmd.105.004218","article-title":"Anti-AIDS agents 65: investigation of the in\u00a0vitro oxidative metabolism of 3',4'-Di-O-(-)-camphanoyl-(+)-cis-khellactone derivatives as potent anti-hiv agents","volume":"33","author":"Suzuki","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"24","key":"10.1016\/j.gendis.2021.03.007_bib35","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1016\/j.bmc.2004.09.038","article-title":"Anti-AIDS agents. Part 56: synthesis and anti-HIV activity of 7-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (7-thia-DCK) analogs","volume":"12","author":"Chen","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"43","key":"10.1016\/j.gendis.2021.03.007_bib36","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1021\/acs.jafc.9b04326","article-title":"Prenylated coumarins from the fruits of Manilkara zapota with potential anti-inflammatory effects and anti-HIV activities","volume":"67","author":"Liu","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.gendis.2021.03.007_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111900","article-title":"Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase","volume":"186","author":"Zhu","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"2\u20133","key":"10.1016\/j.gendis.2021.03.007_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2005.02.006","article-title":"Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway","volume":"66","author":"Marquez","year":"2005","journal-title":"Antivir Res"},{"issue":"8","key":"10.1016\/j.gendis.2021.03.007_bib39","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.3390\/molecules17089245","article-title":"3-Phenylcoumarins as inhibitors of HIV-1 replication","volume":"17","author":"Olmedo","year":"2012","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bmcl.2012.12.034","article-title":"Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells","volume":"23","author":"Kudo","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2014.12.102","article-title":"Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity","volume":"457","author":"Matsuda","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1248\/cpb.50.1634","article-title":"Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity","volume":"50","author":"Mao","year":"2002","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib43","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1248\/cpb.55.1740","article-title":"Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues","volume":"55","author":"Chiang","year":"2007","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.gendis.2021.03.007_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2014.07.008","article-title":"Novel furocoumarins as potential HIV-1 integrase inhibitors","volume":"57","author":"Olomola","year":"2014","journal-title":"Bioorg Chem"},{"issue":"30","key":"10.1016\/j.gendis.2021.03.007_bib45","doi-asserted-by":"crossref","first-page":"E7053","DOI":"10.1073\/pnas.1803909115","article-title":"Affinity switching of the LEDGF\/p75 IBD interactome is governed by kinase-dependent phosphorylation","volume":"115","author":"Sharma","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2021.03.007_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111617","article-title":"Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity","volume":"182","author":"Esposito","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"36","key":"10.1016\/j.gendis.2021.03.007_bib47","doi-asserted-by":"crossref","first-page":"37349","DOI":"10.1074\/jbc.M401993200","article-title":"Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway","volume":"279","author":"Sancho","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2021.03.007_bib48","doi-asserted-by":"crossref","first-page":"173124","DOI":"10.1016\/j.ejphar.2020.173124","article-title":"Imperatorin: a review of its pharmacology, toxicity and pharmacokinetics","volume":"879","author":"Deng","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"17","key":"10.1016\/j.gendis.2021.03.007_bib49","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1128\/JVI.00175-11","article-title":"Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway","volume":"85","author":"Lin","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1248\/cpb.49.877","article-title":"Chemical constituents of Prangos tschiniganica; structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity","volume":"49","author":"Shikishima","year":"2001","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.molcel.2018.05.007","article-title":"Vpr targets TET2 for degradation by CRL4(VprBP) E3 ligase to sustain IL-6 expression and enhance HIV-1 replication","volume":"70","author":"Lv","year":"2018","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01344-19","article-title":"Vpr enhances HIV-1 env processing and virion infectivity in macrophages by modulating TET2-dependent IFITM3 expression","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"issue":"16","key":"10.1016\/j.gendis.2021.03.007_bib53","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1074\/jbc.M110.185397","article-title":"Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR","volume":"286","author":"Ong","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ardp.200800149","article-title":"Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents","volume":"342","author":"Mahajan","year":"2009","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.gendis.2021.03.007_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antivir Res"},{"issue":"13","key":"10.1016\/j.gendis.2021.03.007_bib56","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2021.03.007_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2015.03.013","article-title":"Benzouracil-coumarin-arene conjugates as inhibiting agents for chikungunya virus","volume":"118","author":"Hwu","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.gendis.2021.03.007_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejmech.2019.01.037","article-title":"Chikungunya virus inhibition by synthetic coumarin-guanosine conjugates","volume":"166","author":"Hwu","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.gendis.2021.03.007_bib59","article-title":"Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections","volume":"17","author":"Gomez-Calderon","year":"2017","journal-title":"BMC Compl Alternative Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.03.007_bib60","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1080\/21691401.2019.1640716","article-title":"Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model","volume":"47","author":"Zhong","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41564-018-0319-z","article-title":"Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2","volume":"4","author":"Zhou","year":"2019","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02057-18","article-title":"Predicting intraserotypic recombination in enterovirus 71","volume":"93","author":"Woodman","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.gendis.2021.03.007_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2011.11.001","article-title":"MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71)","volume":"93","author":"Wang","year":"2012","journal-title":"Antivir Res"},{"issue":"24","key":"10.1016\/j.gendis.2021.03.007_bib64","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.bmcl.2005.08.097","article-title":"Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors","volume":"15","author":"Han","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"16","key":"10.1016\/j.gendis.2021.03.007_bib65","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.bmc.2016.05.055","article-title":"Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents","volume":"24","author":"Sun","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib66","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.3390\/molecules18056057","article-title":"Substituted 3-benzylcoumarins as allosteric MEK1 inhibitors: design, synthesis and biological evaluation as antiviral agents","volume":"18","author":"Wang","year":"2013","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib67","first-page":"1045","article-title":"Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention","volume":"33","author":"Lanini","year":"2019","journal-title":"Infect Dis Clin"},{"issue":"18","key":"10.1016\/j.gendis.2021.03.007_bib68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","article-title":"Increase in hepatitis A virus infections - United States, 2013-2018","volume":"68","author":"Foster","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.gendis.2021.03.007_bib69","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/liv.14137","article-title":"Chronic Hepatitis E is associated with cholangitis","volume":"39","author":"Beer","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.gendis.2021.03.007_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9012580","article-title":"HCV and oxidative stress: implications for HCV life cycle and HCV-associated pathogenesis","volume":"2016","author":"Medvedev","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"10.1016\/j.gendis.2021.03.007_bib71","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.3390\/v7122968","article-title":"Mechanisms of hepatitis C viral resistance to direct acting antivirals","volume":"7","author":"Ahmed","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.gendis.2021.03.007_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2019.01.025","article-title":"Hepatitis C - new drugs and treatment prospects","volume":"165","author":"Zajac","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.antiviral.2007.09.003","article-title":"Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents","volume":"77","author":"Hwu","year":"2008","journal-title":"Antivir Res"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib74","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm801240d","article-title":"Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates","volume":"52","author":"Neyts","year":"2009","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib75","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm101337v","article-title":"Coumarin-purine ribofuranoside conjugates as new agent against hepatitis C virus","volume":"54","author":"Hwu","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.gendis.2021.03.007_bib76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejmech.2013.02.008","article-title":"Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus","volume":"63","author":"Tsay","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21020228","article-title":"Synthesis and structure-activity relationships of imidazole-coumarin conjugates against hepatitis C virus","volume":"21","author":"Tsay","year":"2016","journal-title":"Molecules"},{"issue":"5 Suppl","key":"10.1016\/j.gendis.2021.03.007_bib78","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212233","article-title":"Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor","volume":"14","author":"Takeuchi","year":"2019","journal-title":"PloS One"},{"issue":"16","key":"10.1016\/j.gendis.2021.03.007_bib80","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2174\/1389450120666190729115646","article-title":"Potential drug targets against hepatitis B virus based on both virus and host factors","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib81","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/hep.510240307","article-title":"Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in\u00a0vitro","volume":"24","author":"Huang","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.fitote.2011.11.008","article-title":"Lignans from the heartwood of Streblus asper and their inhibiting activities to hepatitis B virus","volume":"83","author":"Li","year":"2012","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib83","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.bmcl.2015.02.022","article-title":"A coumarin lignanoid from the stems of Kadsura heteroclita","volume":"25","author":"Su","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib84","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/10286020.2014.996137","article-title":"Two new coumarin glycosides from Herpetospermum caudigerum","volume":"17","author":"Xu","year":"2015","journal-title":"J Asian Nat Prod Res"},{"issue":"19","key":"10.1016\/j.gendis.2021.03.007_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24193475","article-title":"Anti-hepatitis B virus activity of esculetin from microsorium fortunei in vitro and in vivo","volume":"24","author":"Huang","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib86","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30325","article-title":"Serum hepatitis B virus RNA: a new potential biomarker for chronic hepatitis B virus infection","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.gendis.2021.03.007_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174276","article-title":"Mapping the interactions of HBV cccDNA with host factors","volume":"20","author":"Mohd-Ismail","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib89","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/01478885.2019.1683132","article-title":"Characterization of polyclonal antibodies to herpes simplex virus types 1 and 2","volume":"42","author":"Lloyd","year":"2019","journal-title":"J Histotechnol"},{"issue":"5","key":"10.1016\/j.gendis.2021.03.007_bib90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.gendis.2021.03.007_bib91","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/np800760p","article-title":"7-O-methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii","volume":"72","author":"Tian","year":"2009","journal-title":"J Nat Prod"},{"issue":"7","key":"10.1016\/j.gendis.2021.03.007_bib92","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.3390\/molecules16076023","article-title":"Benzylidene-bis-(4-hydroxycoumarin) and benzopyrano-coumarin derivatives: synthesis, (1)H\/(1)(3)C-NMR conformational and X-ray crystal structure studies and in\u00a0vitro antiviral activity evaluations","volume":"16","author":"Zavrsnik","year":"2011","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.gendis.2021.03.007_bib93","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1021\/acs.orglett.7b02290","article-title":"Cnidimonins A-C, three types of hybrid dimer from Cnidium monnieri: structural elucidation and semisynthesis","volume":"19","author":"Su","year":"2017","journal-title":"Org Lett"},{"issue":"Pt 2","key":"10.1016\/j.gendis.2021.03.007_bib94","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.fct.2017.05.011","article-title":"Antiviral effect of compounds derived from Angelica archangelica L. on Herpes simplex virus-1 and Coxsackievirus B3 infections","volume":"109","author":"Rajtar","year":"2017","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.gendis.2021.03.007_bib95","first-page":"523","article-title":"Anti-viral evaluation of sesquiterpene coumarins from Ferula assa-foetida against HSV-1","volume":"13","author":"Ghannadi","year":"2014","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib96","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2003-44457","article-title":"Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions","volume":"3","author":"Wittkowsky","year":"2003","journal-title":"Semin Vasc Med"},{"issue":"6","key":"10.1016\/j.gendis.2021.03.007_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900380","article-title":"Coumarin-containing hybrids and their antibacterial activities","volume":"353","author":"Feng","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"issue":"4","key":"10.1016\/j.gendis.2021.03.007_bib98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bmcl.2018.12.048","article-title":"Synthetically modified\u00a0methoxsalen for enhanced cytotoxicity in light and\u00a0dark reactions","volume":"29","author":"Guillon","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.gendis.2021.03.007_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2016.01.007","article-title":"Relationship between coumarin-induced hepatocellular toxicity and mitochondrial function in rats","volume":"90","author":"Tanaka","year":"2016","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.gendis.2021.03.007_bib100","first-page":"518","article-title":"[Toxicological research and safety consideration of coumarins]","volume":"45","author":"Guo","year":"2020","journal-title":"Zhongguo Zhongyao Zazhi"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:27:43Z","timestamp":1762450063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304221000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2352304221000465"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2021.03.007","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}